CDR132L clinical trials
CDR132L is named as an intervention in 3 current clinical trials in our Germany, UK, India, Spain, Poland, Japan, South Korea, USA, Canada, Netherlands, Czechia and Australia registers. 3 are recruiting patients now. The most common phase is Phase 2. The lead sponsor is Novo Nordisk A/S. The most-studied condition is Heart Failure.
Patient leaflets for CDR132L
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of CDR132L
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 · Heart Failure
|
Phase 2 | Recruiting | Novo Nordisk A/S | UK, USA, India, Germany, Spain, Poland, Canada, Japan, South Korea |
|
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375 · Heart Failure
|
Phase 2 | Recruiting | Novo Nordisk A/S | UK, India, Germany, Spain, Netherlands, Poland, Czechia, Japan, South Korea, Australia |
|
A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
NCT07656454 · ClinicalTrials.gov ↗ · Healthy Volunteers, Heart Failure
|
Phase 1 | Recruiting | Novo Nordisk A/S | Germany |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with CDR132L
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Novo Nordisk A/S | 3 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about CDR132L trials
How many clinical trials are testing CDR132L?
3 current trials in our Germany, UK, India, Spain, Poland, Japan, South Korea, USA, Canada, Netherlands, Czechia and Australia registers name CDR132L as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.
Are CDR132L trials recruiting patients?
Yes. 3 of the 3 trials are recruiting: 3 with sites in Germany, 2 with sites in UK, 2 with sites in India, 2 with sites in Spain, 2 with sites in Poland, 2 with sites in Japan, 2 with sites in South Korea, 1 with sites in USA, 1 with sites in Canada, 1 with sites in Netherlands, 1 with sites in Czechia and 1 with sites in Australia. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors CDR132L clinical trials?
The lead sponsor is Novo Nordisk A/S. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how CDR132L works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how CDR132L works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists CDR132L (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.